Print

Nimbus Discovery Appoints William F. Westlin, Ph.D., as Head of Preclinical Research and Early Development  
2/6/2013 9:31:28 AM

Nimbus Discovery LLC, a biotechnology company discovering novel medicines against exciting but previously inaccessible drug targets, today announced the appointment of William “Wes” F. Westlin, Ph.D., as Head of Preclinical Research & Early Development. Dr. Westlin joins Nimbus from Celgene, where he was Vice President, Preclinical Research, following Celgene’s acquisition of Avila Therapeutics in 2012.
//-->